{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T21:41:15Z","timestamp":1787002875387,"version":"build-2736575974"},"reference-count":74,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2025,6,24]],"date-time":"2025-06-24T00:00:00Z","timestamp":1750723200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,6,24]],"date-time":"2025-06-24T00:00:00Z","timestamp":1750723200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Hum Genet"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1038\/s41431-025-01901-1","type":"journal-article","created":{"date-parts":[[2025,6,24]],"date-time":"2025-06-24T08:11:06Z","timestamp":1750752666000},"page":"1228-1239","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Houge-Janssens syndrome"],"prefix":"10.1038","volume":"33","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6102-1513","authenticated-orcid":false,"given":"Gunnar Douzgos","family":"Houge","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8890-7544","authenticated-orcid":false,"given":"Sofia Douzgou","family":"Houge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3828-4419","authenticated-orcid":false,"given":"Tzung-Chien","family":"Hsieh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3681-1628","authenticated-orcid":false,"given":"Iris","family":"Verbinnen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6772-8448","authenticated-orcid":false,"given":"Veerle","family":"Janssens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,6,24]]},"reference":[{"key":"1901_CR1","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1038\/s41586-022-05575-3","volume":"613","author":"JL Johnson","year":"2023","unstructured":"Johnson JL, Yaron TM, Huntsman EM, Kerelsky A, Song J, Regev A, et al. An atlas of substrate specificities for the human serine\/threonine kinome. Nature. 2023;613:759\u201366.","journal-title":"Nature"},{"key":"1901_CR2","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/j.cell.2006.09.026","volume":"127","author":"JV Olsen","year":"2006","unstructured":"Olsen JV, Blagoev B, Gnad F, Macek B, Kumar C, Mortensen P, et al. Global, in vivo, and site-specific phosphorylation dynamics in signaling networks. Cell. 2006;127:635\u201348.","journal-title":"Cell"},{"key":"1901_CR3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/gigascience\/giw015","volume":"6","author":"P Vlastaridis","year":"2017","unstructured":"Vlastaridis P, Kyriakidou P, Chaliotis A, Van de Peer Y, Oliver SG, Amoutzias GD. Estimating the total number of phosphoproteins and phosphorylation sites in eukaryotic proteomes. Gigascience. 2017;6:1\u201311.","journal-title":"Gigascience"},{"key":"1901_CR4","first-page":"384","volume":"6","author":"V Janssens","year":"2021","unstructured":"Janssens V. Serine\/threonine protein phosphatases. Encycl Biol Chem. 2021;6:384\u2013397.","journal-title":"Encycl Biol Chem"},{"key":"1901_CR5","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1111\/febs.12077","volume":"280","author":"NK Tonks","year":"2013","unstructured":"Tonks NK. Protein tyrosine phosphatases-from housekeeping enzymes to master regulators of signal transduction. FEBS J. 2013;280:346\u201378.","journal-title":"FEBS J"},{"key":"1901_CR6","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1042\/BST20201313","volume":"49","author":"I Verbinnen","year":"2021","unstructured":"Verbinnen I, Vaneynde P, Reynhout S, Lenaerts L, Derua R, Houge G, et al. Protein Phosphatase 2A (PP2A) mutations in brain function, development, and neurologic disease. Biochem Soc Trans. 2021;49:1567\u201388.","journal-title":"Biochem Soc Trans"},{"key":"1901_CR7","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.bbamcr.2018.07.010","volume":"1866","author":"S Reynhout","year":"2019","unstructured":"Reynhout S, Janssens V. Physiologic functions of PP2A: lessons from genetically modified mice. Biochim Biophys Acta Mol Cell Res. 2019;1866:31\u201350.","journal-title":"Biochim Biophys Acta Mol Cell Res"},{"key":"1901_CR8","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1038\/70493","volume":"23","author":"SE Holmes","year":"1999","unstructured":"Holmes SE, O\u2019Hearn EE, McInnis MG, Gorelick-Feldman DA, Kleiderlein JJ, Callahan C, et al. Expansion of a novel CAG trinucleotide repeat in the 5\u2019 region of PPP2R2B is associated with SCA12. Nat Genet. 1999;23:391\u20132.","journal-title":"Nat Genet"},{"key":"1901_CR9","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1530\/EJE-19-0067","volume":"180","author":"T Guran","year":"2019","unstructured":"Guran T, Yesil G, Turan S, Atay Z, Bozkurtlar E, Aghayev A, et al. PPP2R3C gene variants cause syndromic 46,XY gonadal dysgenesis and impaired spermatogenesis in humans. Eur J Endocrinol. 2019;180:291\u2013309.","journal-title":"Eur J Endocrinol"},{"key":"1901_CR10","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1016\/j.ajhg.2025.01.021","volume":"112","author":"I Verbinnen","year":"2025","unstructured":"Verbinnen I, Douzgou Houge S, Hsieh TC, Lesmann H, Kirchhoff A, Genevi\u00e8ve D. Pathogenic de novo variants in PPP2R5C cause a neurodevelopmental disorder within the Houge-Janssens syndrome spectrum. Am J Hum Genet. 2025;112:554\u201371.","journal-title":"Am J Hum Genet"},{"key":"1901_CR11","doi-asserted-by":"crossref","DOI":"10.1016\/j.gene.2024.148945","volume":"933","author":"A Musumeci","year":"2025","unstructured":"Musumeci A, Vinci M, Verbinnen I, Treccarichi S, Nigliato E, Chiavetta V, et al. PPP2R5E: new gene potentially involved in specific learning disorders and myopathy. Gene. 2025;933:148945.","journal-title":"Gene"},{"key":"1901_CR12","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1016\/j.molcel.2016.06.024","volume":"63","author":"EPT Hertz","year":"2016","unstructured":"Hertz EPT, Kruse T, Davey NE, Lopez-Mendez B, Sigurethsson JO, Montoya G, et al. A conserved motif provides binding specificity to the PP2A-B56 phosphatase. Mol Cell. 2016;63:686\u201395.","journal-title":"Mol Cell"},{"key":"1901_CR13","doi-asserted-by":"crossref","first-page":"2174","DOI":"10.1016\/j.str.2016.09.010","volume":"24","author":"X Wang","year":"2016","unstructured":"Wang X, Bajaj R, Bollen M, Peti W, Page R. Expanding the PP2A interactome by defining a B56-specific SLiM. Structure. 2016;24:2174\u201381.","journal-title":"Structure"},{"key":"1901_CR14","volume":"3","author":"CG Wu","year":"2017","unstructured":"Wu CG, Chen H, Guo F, Yadav VK, McIlwain SJ, Rowse M, et al. PP2A-B\u2019 holoenzyme substrate recognition, regulation and role in cytokinesis. Cell Discov. 2017;3:17027.","journal-title":"Cell Discov"},{"key":"1901_CR15","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-020-18874-y","volume":"11","author":"MS Barski","year":"2020","unstructured":"Barski MS, Minnell JJ, Hodakova Z, Pye VE, Nans A, Cherepanov P, et al. Cryo-EM structure of the deltaretroviral intasome in complex with the PP2A regulatory subunit B56gamma. Nat Commun. 2020;11:5043.","journal-title":"Nat Commun"},{"key":"1901_CR16","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1083\/jcb.201606033","volume":"214","author":"MJ Cundell","year":"2016","unstructured":"Cundell MJ, Hutter LH, Nunes Bastos R, Poser E, Holder J, Mohammed S, et al. A PP2A-B55 recognition signal controls substrate dephosphorylation kinetics during mitotic exit. J Cell Biol. 2016;214:539\u201354.","journal-title":"J Cell Biol"},{"key":"1901_CR17","doi-asserted-by":"crossref","unstructured":"Fowle H, Zhao Z, Xu Q, Wasserman JS, Wang X, Adeyemi M et al. PP2A\/B55alpha substrate recruitment as defined by the retinoblastoma-related protein p107. Elife. 2021;10:63181.","DOI":"10.7554\/eLife.63181"},{"key":"1901_CR18","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1038\/s41586-023-06870-3","volume":"625","author":"SKR Padi","year":"2024","unstructured":"Padi SKR, Vos MR, Godek RJ, Fuller JR, Kruse T, Hein JB, et al. Cryo-EM structures of PP2A:B55-FAM122A and PP2A:B55-ARPP19. Nature. 2024;625:195\u2013203.","journal-title":"Nature"},{"key":"1901_CR19","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.adp5491","volume":"10","author":"T Kruse","year":"2024","unstructured":"Kruse T, Garvanska DH, Varga JK, Garland W, McEwan BC, Hein JB, et al. Substrate recognition principles for the PP2A-B55 protein phosphatase. Sci Adv. 2024;10:eadp5491.","journal-title":"Sci Adv"},{"key":"1901_CR20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41388-021-02068-x","volume":"41","author":"P Amin","year":"2022","unstructured":"Amin P, Awal S, Vigneron S, Roque S, Mechali F, Labbe JC, et al. PP2A-B55: substrates and regulators in the control of cellular functions. Oncogene. 2022;41:1\u201314.","journal-title":"Oncogene"},{"key":"1901_CR21","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbcan.2023.188953","volume":"1878","author":"I Peris","year":"2023","unstructured":"Peris I, Romero-Murillo S, Vicente C, Narla G, Odero MD. Regulation and role of the PP2A-B56 holoenzyme family in cancer. Biochim Biophys Acta Rev Cancer. 2023;1878:188953.","journal-title":"Biochim Biophys Acta Rev Cancer"},{"key":"1901_CR22","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/j.cell.2009.10.006","volume":"139","author":"Y Shi","year":"2009","unstructured":"Shi Y. Serine\/threonine phosphatases: mechanism through structure. Cell. 2009;139:468\u201384.","journal-title":"Cell"},{"key":"1901_CR23","doi-asserted-by":"crossref","DOI":"10.15252\/embj.2019103695","volume":"39","author":"T Kruse","year":"2020","unstructured":"Kruse T, Gnosa SP, Nasa I, Garvanska DH, Hein JB, Nguyen H, et al. Mechanisms of site-specific dephosphorylation and kinase opposition imposed by PP2A regulatory subunits. EMBO J. 2020;39:e103695.","journal-title":"EMBO J"},{"key":"1901_CR24","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1111\/j.1742-4658.2012.08579.x","volume":"280","author":"W Sents","year":"2013","unstructured":"Sents W, Ivanova E, Lambrecht C, Haesen D, Janssens V. The biogenesis of active protein phosphatase 2A holoenzymes: a tightly regulated process creating phosphatase specificity. FEBS J. 2013;280:644\u201361.","journal-title":"FEBS J"},{"key":"1901_CR25","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1007\/s13402-024-00963-5","volume":"47","author":"M Remmerie","year":"2024","unstructured":"Remmerie M, Dok R, Wang Z, Omella JD, Alen S, Cokelaere C, et al. The PPP2R1A cancer hotspot mutant p.R183W increases clofarabine resistance in uterine serous carcinoma cells by a gain-of-function mechanism. Cell Oncol. 2024;47:1811\u201329.","journal-title":"Cell Oncol"},{"key":"1901_CR26","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1006\/abbi.1996.9835","volume":"339","author":"T Zhu","year":"1997","unstructured":"Zhu T, Matsuzawa S, Mizuno Y, Kamibayashi C, Mumby MC, Andjelkovic N, et al. The interconversion of protein phosphatase 2A between PP2A1 and PP2A0 during retinoic acid-induced granulocytic differentiation and a modification on the catalytic subunit in S phase of HL-60 cells. Arch Biochem Biophys. 1997;339:210\u20137.","journal-title":"Arch Biochem Biophys"},{"key":"1901_CR27","doi-asserted-by":"crossref","first-page":"26971","DOI":"10.1074\/jbc.M704059200","volume":"282","author":"S Longin","year":"2007","unstructured":"Longin S, Zwaenepoel K, Louis JV, Dilworth S, Goris J, Janssens V. Selection of protein phosphatase 2A regulatory subunits is mediated by the C terminus of the catalytic Subunit. J Biol Chem. 2007;282:26971\u201380.","journal-title":"J Biol Chem"},{"key":"1901_CR28","doi-asserted-by":"crossref","first-page":"6825","DOI":"10.1158\/0008-5472.CAN-16-2911","volume":"77","author":"W Sents","year":"2017","unstructured":"Sents W, Meeusen B, Kalev P, Radaelli E, Sagaert X, Miermans E, et al. PP2A inactivation mediated by PPP2R4 haploinsufficiency promotes cancer development. Cancer Res. 2017;77:6825\u201337.","journal-title":"Cancer Res"},{"key":"1901_CR29","doi-asserted-by":"crossref","first-page":"1692","DOI":"10.1128\/MCB.17.3.1692","volume":"17","author":"E Kremmer","year":"1997","unstructured":"Kremmer E, Ohst K, Kiefer J, Brewis N, Walter G. Separation of PP2A core enzyme and holoenzyme with monoclonal antibodies against the regulatory A subunit: abundant expression of both forms in cells. Mol Cell Biol. 1997;17:1692\u2013701.","journal-title":"Mol Cell Biol"},{"key":"1901_CR30","unstructured":"Mirzaa G, Foss K, Nattakom M, Chung WK. PPP2R5D-related neurodevelopmental disorder. Seattle, WA: GeneReviews((R)); 2019."},{"key":"1901_CR31","unstructured":"Douzgou S, Janssens V, Houge G. PPP2R1A-related neurodevelopmental disorder. Seattle, WA: GeneReviews((R)); 2022."},{"key":"1901_CR32","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.ajhg.2019.01.003","volume":"104","author":"S Reynhout","year":"2019","unstructured":"Reynhout S, Jansen S, Haesen D, van Belle S, de Munnik SA, Bongers E, et al. De novo mutations affecting the catalytic calpha subunit of PP2A, PPP2CA, cause syndromic intellectual disability resembling other PP2A-related neurodevelopmental disorders. Am J Hum Genet. 2019;104:357.","journal-title":"Am J Hum Genet"},{"key":"1901_CR33","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1038\/s41576-023-00574-0","volume":"24","author":"J Zschocke","year":"2023","unstructured":"Zschocke J, Byers PH, Wilkie AOM. Mendelian inheritance revisited: dominance and recessiveness in medical genetics. Nat Rev Genet. 2023;24:442\u201363.","journal-title":"Nat Rev Genet"},{"key":"1901_CR34","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.ajhg.2011.12.017","volume":"90","author":"A Goriely","year":"2012","unstructured":"Goriely A, Wilkie AO. Paternal age effect mutations and selfish spermatogonial selection: causes and consequences for human disease. Am J Hum Genet. 2012;90:175\u2013200.","journal-title":"Am J Hum Genet"},{"key":"1901_CR35","doi-asserted-by":"crossref","unstructured":"Lei T, Zhen L, Yang X, Pan M, Fu F, Han J et al. Prenatal diagnosis of PPP2R1A-related neurodevelopmental disorders using whole exome sequencing: clinical report and review of literature. Genes. 2023;14:126.","DOI":"10.3390\/genes14010126"},{"key":"1901_CR36","doi-asserted-by":"crossref","first-page":"3262","DOI":"10.1002\/ajmg.a.62946","volume":"188","author":"EK Baker","year":"2022","unstructured":"Baker EK, Solivio B, Pode-Shakked B, Cross LA, Sullivan B, Raas-Rothschild A, et al. PPP2R1A neurodevelopmental disorder is associated with congenital heart defects. Am J Med Genet A. 2022;188:3262\u201377.","journal-title":"Am J Med Genet A"},{"key":"1901_CR37","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1002\/pd.6641","volume":"44","author":"X Wei","year":"2024","unstructured":"Wei X, Cai L, Zhang L, Chen J, Zhang Y, Meng M, et al. Prenatal diagnosed agenesis of the corpus callosum: identifying the underlying genetic etiologies. Prenat Diagn. 2024;44:1142\u20139.","journal-title":"Prenat Diagn"},{"key":"1901_CR38","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1038\/s41436-020-00981-2","volume":"23","author":"L Lenaerts","year":"2021","unstructured":"Lenaerts L, Reynhout S, Verbinnen I, Laumonnier F, Toutain A, Bonnet-Brilhault F, et al. The broad phenotypic spectrum of PPP2R1A-related neurodevelopmental disorders correlates with the degree of biochemical dysfunction. Genet Med. 2021;23:352\u201362.","journal-title":"Genet Med"},{"key":"1901_CR39","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2022.1059938","volume":"10","author":"I Verbinnen","year":"2022","unstructured":"Verbinnen I, Procknow SS, Lenaerts L, Reynhout S, Mehregan A, Ulens C, et al. Clinical and molecular characteristics of a novel rare de novo variant in PPP2CA in a patient with a developmental disorder, autism, and epilepsy. Front Cell Dev Biol. 2022;10:1059938.","journal-title":"Front Cell Dev Biol"},{"key":"1901_CR40","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1002\/ana.25863","volume":"88","author":"CY Kim","year":"2020","unstructured":"Kim CY, Wirth T, Hubsch C, Nemeth AH, Okur V, Anheim M, et al. Early-onset parkinsonism is a manifestation of the PPP2R5D p.E200K mutation. Ann Neurol. 2020;88:1028\u201333.","journal-title":"Ann Neurol"},{"key":"1901_CR41","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmg.2020.104123","volume":"64","author":"K Hetzelt","year":"2021","unstructured":"Hetzelt K, Kerling F, Kraus C, Rauch C, Thiel CT, Winterholler M, et al. Early-onset parkinsonism in PPP2R5D-related neurodevelopmental disorder. Eur J Med Genet. 2021;64:104123.","journal-title":"Eur J Med Genet"},{"key":"1901_CR42","doi-asserted-by":"crossref","DOI":"10.1016\/j.neulet.2022.136564","volume":"776","author":"P Ning","year":"2022","unstructured":"Ning P, Li K, Ren H, Yang H, Xu Y, Yang X. Rare missense variants in the PPP2R5D gene associated with Parkinson\u2019s disease in the Han Chinese population. Neurosci Lett. 2022;776:136564.","journal-title":"Neurosci Lett"},{"key":"1901_CR43","doi-asserted-by":"crossref","DOI":"10.1016\/j.parkreldis.2024.106952","volume":"123","author":"R Mahale","year":"2024","unstructured":"Mahale R, Arunachal G, Chadha D, Padmanabha H, Pavagada MP. M: Early-onset levodopa responsive parkinsonism in PPP2R5D mutation. Parkinsonism Relat Disord. 2024;123:106952.","journal-title":"Parkinsonism Relat Disord"},{"key":"1901_CR44","volume":"124","author":"WY Yau","year":"2024","unstructured":"Yau WY, Vijayan S, Ravenscroft G. PPP2R5D heterozygous pathogenic variant causes early-onset parkinsonism and treatment implications: a case report. Parkinsonism Relat Disord. 2024;124:106976.","journal-title":"Parkinsonism Relat Disord"},{"key":"1901_CR45","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1080\/15548627.2015.1086055","volume":"11","author":"TT Du","year":"2015","unstructured":"Du TT, Wang L, Duan CL, Lu LL, Zhang JL, Gao G, et al. GBA deficiency promotes SNCA\/alpha-synuclein accumulation through autophagic inhibition by inactivated PPP2A. Autophagy. 2015;11:1803\u201320.","journal-title":"Autophagy"},{"key":"1901_CR46","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1093\/brain\/awac326","volume":"146","author":"C Fevga","year":"2023","unstructured":"Fevga C, Tesson C, Carreras Mascaro A, Courtin T, van Coller R, Sakka S, et al. PTPA variants and impaired PP2A activity in early-onset parkinsonism with intellectual disability. Brain. 2023;146:1496\u2013510.","journal-title":"Brain"},{"key":"1901_CR47","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1038\/s41588-021-01010-x","volume":"54","author":"TC Hsieh","year":"2022","unstructured":"Hsieh TC, Bar-Haim A, Moosa S, Ehmke N, Gripp KW, Pantel JT, et al. GestaltMatcher facilitates rare disease matching using facial phenotype descriptors. Nat Genet. 2022;54:349\u201357.","journal-title":"Nat Genet"},{"key":"1901_CR48","doi-asserted-by":"crossref","first-page":"3051","DOI":"10.1172\/JCI79860","volume":"125","author":"G Houge","year":"2015","unstructured":"Houge G, Haesen D, Vissers LE, Mehta S, Parker MJ, Wright M, et al. B56delta-related protein phosphatase 2A dysfunction identified in patients with intellectual disability. J Clin Invest. 2015;125:3051\u201362.","journal-title":"J Clin Invest"},{"key":"1901_CR49","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/s10048-015-0466-9","volume":"17","author":"L Shang","year":"2016","unstructured":"Shang L, Henderson LB, Cho MT, Petrey DS, Fong CT, Haude KM, et al. De novo missense variants in PPP2R5D are associated with intellectual disability, macrocephaly, hypotonia, and autism. Neurogenetics. 2016;17:43\u201349.","journal-title":"Neurogenetics"},{"key":"1901_CR50","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1007\/s42000-021-00287-1","volume":"20","author":"E Maines","year":"2021","unstructured":"Maines E, Franceschi R, Martinelli D, Soli F, Lepri FR, Piccoli G, et al. Hypoglycemia due to PI3K\/AKT\/mTOR signaling pathway defects: two novel cases and review of the literature. Hormones. 2021;20:623\u201340.","journal-title":"Hormones"},{"key":"1901_CR51","doi-asserted-by":"crossref","first-page":"4775","DOI":"10.1093\/hmg\/ddv182","volume":"24","author":"C Loveday","year":"2015","unstructured":"Loveday C, Tatton-Brown K, Clarke M, Westwood I, Renwick A, Ramsay E, et al. Mutations in the PP2A regulatory subunit B family genes PPP2R5B, PPP2R5C and PPP2R5D cause human overgrowth. Hum Mol Genet. 2015;24:4775\u20139.","journal-title":"Hum Mol Genet"},{"key":"1901_CR52","doi-asserted-by":"crossref","DOI":"10.1186\/s13229-017-0182-4","volume":"8","author":"KS Yeung","year":"2017","unstructured":"Yeung KS, Tso WWY, Ip JJK, Mak CCY, Leung GKC, Tsang MHY, et al. Identification of mutations in the PI3K-AKT-mTOR signalling pathway in patients with macrocephaly and developmental delay and\/or autism. Mol Autism. 2017;8:66.","journal-title":"Mol Autism"},{"key":"1901_CR53","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1136\/jmg-2022-108713","volume":"60","author":"N Oyama","year":"2023","unstructured":"Oyama N, Vaneynde P, Reynhout S, Pao EM, Timms A, Fan X, et al. Clinical, neuroimaging and molecular characteristics of PPP2R5D-related neurodevelopmental disorders: an expanded series with functional characterisation and genotype-phenotype analysis. J Med Genet. 2023;60:511\u201322.","journal-title":"J Med Genet"},{"key":"1901_CR54","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1038\/s42003-022-03989-3","volume":"5","author":"M Ripamonti","year":"2022","unstructured":"Ripamonti M, Lamarca A, Davey NE, Tonoli D, Surini S, de Curtis I. A functional interaction between liprin-alpha1 and B56gamma regulatory subunit of protein phosphatase 2A supports tumor cell motility. Commun Biol. 2022;5:1025.","journal-title":"Commun Biol"},{"key":"1901_CR55","doi-asserted-by":"crossref","unstructured":"Mayer A, Derua R, Spahn E, Verbinnen I, Zhang Y, Wadzinski B et al: The role of liprin-alpha1 phosphorylation in its liquid-liquid phase separation: regulation by PPP2R5D\/PP2A holoenzyme. bioRxiv. 2024. https:\/\/www.biorxiv.org\/content\/10.1101\/2024.06.18.599485v1.","DOI":"10.1101\/2024.06.18.599485"},{"key":"1901_CR56","volume":"121","author":"CG Wu","year":"2024","unstructured":"Wu CG, Balakrishnan VK, Merrill RA, Parihar PS, Konovolov K, Chen YC, et al. B56delta long-disordered arms form a dynamic PP2A regulation interface coupled with global allostery and Jordan\u2019s syndrome mutations. Proc Natl Acad Sci USA. 2024;121:e2310727120.","journal-title":"Proc Natl Acad Sci USA"},{"key":"1901_CR57","volume":"223","author":"R Liu","year":"2022","unstructured":"Liu R, Huang Y, Li C, Wang P, Wang Y, Zhang L. A novel nonsense mutation in PPP2R5D is associated with neurodevelopmental disorders and shows incomplete penetrance in a Chinese pedigree. Clin Neurol Neurosurg. 2022;223:107524.","journal-title":"Clin Neurol Neurosurg"},{"key":"1901_CR58","doi-asserted-by":"crossref","first-page":"47732","DOI":"10.1074\/jbc.M408015200","volume":"279","author":"S Strack","year":"2004","unstructured":"Strack S, Cribbs JT, Gomez L. Critical role for protein phosphatase 2A heterotrimers in mammalian cell survival. J Biol Chem. 2004;279:47732\u20139.","journal-title":"J Biol Chem"},{"key":"1901_CR59","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1002\/dvdy.24111","volume":"243","author":"P Varadkar","year":"2014","unstructured":"Varadkar P, Despres D, Kraman M, Lozier J, Phadke A, Nagaraju K, et al. The protein phosphatase 2A B56gamma regulatory subunit is required for heart development. Dev Dyn. 2014;243:778\u201390.","journal-title":"Dev Dyn"},{"key":"1901_CR60","doi-asserted-by":"crossref","first-page":"6957","DOI":"10.1073\/pnas.1018777108","volume":"108","author":"JV Louis","year":"2011","unstructured":"Louis JV, Martens E, Borghgraef P, Lambrecht C, Sents W, Longin S, et al. Mice lacking phosphatase PP2A subunit PR61\/B\u2019delta (Ppp2r5d) develop spatially restricted tauopathy by deregulation of CDK5 and GSK3beta. Proc Natl Acad Sci USA. 2011;108:6957\u201362.","journal-title":"Proc Natl Acad Sci USA"},{"key":"1901_CR61","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1096\/fba.2021-00130","volume":"4","author":"JJ Dyson","year":"2022","unstructured":"Dyson JJ, Abbasi F, Varadkar P, McCright B. Growth arrest of PPP2R5C and PPP2R5D double knockout mice indicates a genetic interaction and conserved function for these PP2A B subunits. FASEB Bioadv. 2022;4:273\u201382.","journal-title":"FASEB Bioadv"},{"key":"1901_CR62","doi-asserted-by":"crossref","first-page":"12370","DOI":"10.1073\/pnas.95.21.12370","volume":"95","author":"J Gotz","year":"1998","unstructured":"Gotz J, Probst A, Ehler E, Hemmings B, Kues W. Delayed embryonic lethality in mice lacking protein phosphatase 2A catalytic subunit Calpha. Proc Natl Acad Sci USA. 1998;95:12370\u20135.","journal-title":"Proc Natl Acad Sci USA"},{"key":"1901_CR63","doi-asserted-by":"crossref","first-page":"3832","DOI":"10.1128\/MCB.05744-11","volume":"31","author":"R Ruediger","year":"2011","unstructured":"Ruediger R, Ruiz J, Walter G. Human cancer-associated mutations in the Aalpha subunit of protein phosphatase 2A increase lung cancer incidence in Aalpha knock-in and knockout mice. Mol Cell Biol. 2011;31:3832\u201344.","journal-title":"Mol Cell Biol"},{"key":"1901_CR64","doi-asserted-by":"crossref","first-page":"358","DOI":"10.3389\/fcell.2020.00358","volume":"8","author":"N Panicker","year":"2020","unstructured":"Panicker N, Coutman M, Lawlor-O\u2019Neill C, Kahl RGS, Roselli S, Verrills NM. Ppp2r2a knockout mice reveal that protein phosphatase 2A regulatory subunit, PP2A-B55alpha, is an essential regulator of neuronal and epidermal embryonic development. Front Cell Dev Biol. 2020;8:358.","journal-title":"Front Cell Dev Biol"},{"key":"1901_CR65","doi-asserted-by":"crossref","unstructured":"Sandal P, Jong CJ, Merrill RA, Kollman GJ, Paden AH, Bend EG, et al. De novo missense variants in the PP2A regulatory subunit PPP2R2B in a neurodevelopmental syndrome: potential links to mitochondrial dynamics and spinocerebellar ataxias. Hum Mol Genet. 2024;34:193\u2013203.","DOI":"10.1093\/hmg\/ddae166"},{"key":"1901_CR66","doi-asserted-by":"crossref","first-page":"5719","DOI":"10.1158\/0008-5472.CAN-15-3342","volume":"76","author":"D Haesen","year":"2016","unstructured":"Haesen D, Abbasi Asbagh L, Derua R, Hubert A, Schrauwen S, Hoorne Y, et al. Recurrent PPP2R1A mutations in uterine cancer act through a dominant-negative mechanism to promote malignant cell growth. Cancer Res. 2016;76:5719\u201331.","journal-title":"Cancer Res"},{"key":"1901_CR67","doi-asserted-by":"crossref","first-page":"22081","DOI":"10.1074\/jbc.271.36.22081","volume":"271","author":"B McCright","year":"1996","unstructured":"McCright B, Rivers AM, Audlin S, Virshup DM. The B56 family of protein phosphatase 2A (PP2A) regulatory subunits encodes differentiation-induced phosphoproteins that target PP2A to both nucleus and cytoplasm. J Biol Chem. 1996;271:22081\u20139.","journal-title":"J Biol Chem"},{"key":"1901_CR68","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2025.108834","volume":"269","author":"DA Neale","year":"2025","unstructured":"Neale DA, Morris JC, Verrills NM, Ammit AJ. Understanding the regulatory landscape of protein phosphatase 2A (PP2A): Pharmacological modulators and potential therapeutics. Pharm Ther. 2025;269:108834.","journal-title":"Pharm Ther"},{"key":"1901_CR69","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2021.100313","volume":"296","author":"CM Papke","year":"2021","unstructured":"Papke CM, Smolen KA, Swingle MR, Cressey L, Heng RA, Toporsian M, et al. A disorder-related variant (E420K) of a PP2A-regulatory subunit (PPP2R5D) causes constitutively active AKT-mTOR signaling and uncoordinated cell growth. J Biol Chem. 2021;296:100313.","journal-title":"J Biol Chem"},{"key":"1901_CR70","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2023.105154","volume":"299","author":"KA Smolen","year":"2023","unstructured":"Smolen KA, Papke CM, Swingle MR, Musiyenko A, Li C, Salter EA, et al. Quantitative proteomics and phosphoproteomics of PP2A-PPP2R5D variants reveal deregulation of RPS6 phosphorylation via converging signaling cascades. J Biol Chem. 2023;299:105154.","journal-title":"J Biol Chem"},{"key":"1901_CR71","doi-asserted-by":"crossref","unstructured":"Carter JL, Halmai J, Waldo JJ, Vij PA, Anguiano M, Villegas IJ et al. A de novo missense mutation in PPP2R5D alters dopamine pathways and morphology of iPSC-derived midbrain neurons. Stem Cells. 2024:sxae068.","DOI":"10.1093\/stmcls\/sxae068"},{"key":"1901_CR72","doi-asserted-by":"crossref","first-page":"6963","DOI":"10.1523\/JNEUROSCI.6513-10.2011","volume":"31","author":"KW Lee","year":"2011","unstructured":"Lee KW, Chen W, Junn E, Im JY, Grosso H, Sonsalla PK, et al. Enhanced phosphatase activity attenuates alpha-synucleinopathy in a mouse model. J Neurosci. 2011;31:6963\u201371.","journal-title":"J Neurosci"},{"key":"1901_CR73","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1002\/1873-3468.12907","volume":"592","author":"G Taleski","year":"2018","unstructured":"Taleski G, Sontag E. Protein phosphatase 2A and tau: an orchestrated \u2018Pas de Deux. FEBS Lett. 2018;592:1079\u201395.","journal-title":"FEBS Lett"},{"key":"1901_CR74","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1038\/s41431-025-01787-z","volume":"33","author":"A Kirchhoff","year":"2025","unstructured":"Kirchhoff A, Hustinx A, Javanmardi B, Hsieh TC, Brand F, Hellmann F, et al. GestaltGAN: synthetic photorealistic portraits of individuals with rare genetic disorders. Eur J Hum Genet. 2025;33:377\u201382.","journal-title":"Eur J Hum Genet"}],"container-title":["European Journal of Human Genetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41431-025-01901-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41431-025-01901-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41431-025-01901-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T09:25:52Z","timestamp":1759137952000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41431-025-01901-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,24]]},"references-count":74,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2025,10]]}},"alternative-id":["1901"],"URL":"https:\/\/doi.org\/10.1038\/s41431-025-01901-1","relation":{},"ISSN":["1018-4813","1476-5438"],"issn-type":[{"value":"1018-4813","type":"print"},{"value":"1476-5438","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,24]]},"assertion":[{"value":"14 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 May 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 June 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 June 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}